Profusa, Inc. Common Stock (PFSA) Stock Analysis

Profusa, Inc. Common Stock (PFSA) is a publicly traded company in the HEALTHCARE sector. It trades at $0.32, carries a market capitalization of $1.60M. This page summarizes the public market data, fundamentals, and frequently asked questions for PFSA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $0.32
• Market Cap: $1.60M
• EPS: $-15.36
• 52-Week High: $412.50
• 52-Week Low: $0.33

Market Sentiment

Profusa, Inc. Common Stock currently has a Neutral sentiment score of -0.08.

About Profusa, Inc. Common Stock

Profusa, Inc. (PFSA) is an innovative biotechnology firm headquartered in Emeryville, California, focused on pioneering bioengineered sensing technologies that integrate harmoniously with the human body. Its cutting-edge sensors facilitate continuous, real-time monitoring of essential health indicators, thereby enhancing both personal and clinical health management. By delivering clinical-grade data, Profusa is on a mission to improve patient outcomes and revolutionize healthcare through its ...

GNG Research Analysis

GNG Research scores Profusa, Inc. Common Stock (PFSA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PFSA.

Frequently Asked Questions

Does PFSA pay dividends?

Profusa, Inc. Common Stock (PFSA) does not currently pay a regular dividend.

What is PFSA's market cap?

Profusa, Inc. Common Stock (PFSA) has a market capitalization of $1.60M with a current stock price of $0.32.